US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist

15.170
+1.260+9.06%

Close May 3 16:00 ET

15.170
0.0000.00%

Post 16:01 ET

320.94MMarket Cap-2308P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Dec 31, 2023

(FY)Sep 30, 2023

(Q4)Sep 30, 2023

(Q3)Jun 30, 2023

(Q2)Mar 31, 2023

(Q1)Dec 31, 2022

(FY)Sep 30, 2022

(Q4)Sep 30, 2022

(Q3)Jun 30, 2022

(Q2)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

-21.12%-84.78M

26.10%-15.53M

-0.33%-29.6M

-476.00%-26.38M

Net income from continuing operations

-15.25%-33.41M

-9.91%-133.82M

-6.68%-28.11M

-23.23%-39.07M

-12.10%-37.66M

3.75%-28.99M

-54.13%-121.76M

-7.11%-26.35M

-31.95%-31.7M

-52.38%-33.59M

Operating gains losses

----

--150K

--143K

--0

----

Depreciation and amortization

25.64%642K

-20.25%2.37M

2.14%669K

-9.08%651K

-34.31%540K

-34.49%511K

-10.83%2.97M

-18.73%655K

-13.00%716K

-1.44%822K

Deferred tax

----

--0

----

--0

----

Other non cash items

--786K

-464.37%-5.24M

-8,534.94%-7.17M

4,568.18%1.97M

----

77.33%-929K

87.63%-83K

97.99%-44K

-53.99%-328K

Change In working capital

90.10%-1.38M

18.19%8.02M

84.98%6.21M

80.67%-1.23M

13,186.92%17.01M

-240.64%-13.97M

149.60%6.79M

217.55%3.36M

37.28%-6.37M

-101.18%-130K

-Change in receivables

87.17%-289K

-20.15%9.42M

726.18%5.19M

336.88%1.76M

-47.19%4.72M

-150.81%-2.25M

148.54%11.8M

90.40%-829K

96.09%-743K

6.09%8.94M

-Change in prepaid assets

100.40%18K

-75.50%182K

299.90%3.81M

-201.93%-2.59M

234.60%3.46M

-267.82%-4.5M

239.40%743K

7.12%-1.91M

-63.54%2.54M

-171.31%-2.57M

-Change in payables and accrued expense

78.56%-1.56M

39.31%-3.71M

-153.38%-3.04M

92.31%-579K

205.45%7.2M

-386.47%-7.29M

-150.40%-6.11M

-31.01%5.7M

-450.42%-7.53M

-287.42%-6.82M

-Change in other current assets

73.86%1.45M

7.65%4.49M

68.98%1.44M

116.39%1.16M

-21.59%1.06M

-41.92%834K

-23.00%4.17M

-39.17%851K

-63.07%537K

-4.60%1.35M

-Change in other current liabilities

-36.99%-1.04M

38.11%-2.36M

-159.39%-1.19M

15.78%-987K

156.44%574K

34.91%-757K

40.46%-3.81M

74.89%-458K

30.81%-1.17M

31.65%-1.02M

-Change in other working capital

860.00%38K

----

---5K

----

Cash from discontinued investing activities

Operating cash flow

29.89%-24.99M

-21.67%-103.15M

-39.06%-21.6M

-8.53%-32.13M

47.74%-13.78M

-168.56%-35.64M

-21.12%-84.78M

26.10%-15.53M

-0.33%-29.6M

-476.00%-26.38M

Investing cash flow

Cash flow from continuing investing activities

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

48.41%54.9M

-61.16%28.23M

137.11%16.22M

-237.70%-35.06M

Net PPE purchase and sale

75.06%-787K

-326.26%-9.06M

4.80%-1.37M

-756.97%-2.15M

-3,120.27%-2.38M

-769.42%-3.16M

-183.33%-2.13M

-4,254.55%-1.44M

37.09%-251K

43.08%-74K

Net investment purchase and sale

-133.57%-12.33M

-178.08%-44.52M

-55.49%13.2M

-971.82%-143.6M

240.50%49.15M

-19.93%36.73M

51.09%57.02M

-59.20%29.67M

138.03%16.47M

-236.71%-34.98M

Cash from discontinued investing activities

Investing cash flow

-139.07%-13.12M

-197.60%-53.58M

-58.07%11.84M

-998.57%-145.75M

233.40%46.77M

-26.22%33.57M

48.41%54.9M

-61.16%28.23M

137.11%16.22M

-237.70%-35.06M

Financing cash flow

Cash flow from continuing financing activities

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

550.42%20.03M

210.71%2.93M

500.58%4.12M

190.89%3.35M

Net issuance payments of debt

---7.17M

----

--0

----

Proceeds from stock option exercised by employees

--0

-89.62%2.21M

--0

-95.15%200K

-76.80%882K

-89.18%1.13M

488.32%21.26M

210.82%2.93M

500.58%4.12M

230.03%3.8M

Net other financing activities

77.82%-183K

16,041.25%195.92M

-2,200.00%-23K

--199.68M

-545.01%-2.91M

-6.18%-825K

-130.15%-1.23M

---1K

--0

---451K

Cash from discontinued financing activities

Financing cash flow

-2,541.86%-7.35M

889.00%198.13M

-100.78%-23K

4,751.33%199.88M

-160.49%-2.03M

-96.88%301K

550.42%20.03M

210.71%2.93M

500.58%4.12M

190.89%3.35M

Net cash flow

Beginning cash position

86.31%89.36M

-17.04%47.96M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

-17.04%47.96M

-34.11%57.81M

520.75%32.34M

-46.49%41.6M

78.94%99.68M

Current changes in cash

-2,466.63%-45.46M

520.16%41.39M

-162.64%-9.79M

337.52%22M

153.30%30.96M

-104.23%-1.77M

67.08%-9.85M

-70.29%15.63M

87.23%-9.26M

-363.62%-58.08M

End cash Position

-4.96%43.9M

86.31%89.36M

206.62%99.15M

85.46%77.15M

-53.66%46.19M

-17.04%47.96M

520.75%32.34M

-46.49%41.6M

Free cash flow

33.56%-25.78M

-29.12%-112.21M

-35.35%-22.97M

-14.83%-34.28M

38.88%-16.17M

-184.56%-38.8M

-22.84%-86.91M

19.39%-16.97M

0.17%-29.85M

-461.67%-26.45M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Dec 31, 2023	(FY)Sep 30, 2023	(Q4)Sep 30, 2023	(Q3)Jun 30, 2023	(Q2)Mar 31, 2023	(Q1)Dec 31, 2022	(FY)Sep 30, 2022	(Q4)Sep 30, 2022	(Q3)Jun 30, 2022	(Q2)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M	-21.12%-84.78M	26.10%-15.53M	-0.33%-29.6M	-476.00%-26.38M
Net income from continuing operations	-15.25%-33.41M	-9.91%-133.82M	-6.68%-28.11M	-23.23%-39.07M	-12.10%-37.66M	3.75%-28.99M	-54.13%-121.76M	-7.11%-26.35M	-31.95%-31.7M	-52.38%-33.59M
Operating gains losses	----	--150K	--143K	--0	----	----	----	----	----	----
Depreciation and amortization	25.64%642K	-20.25%2.37M	2.14%669K	-9.08%651K	-34.31%540K	-34.49%511K	-10.83%2.97M	-18.73%655K	-13.00%716K	-1.44%822K
Deferred tax	----	--0	----	----	----	----	--0	----	----	----
Other non cash items	--786K	-464.37%-5.24M	-8,534.94%-7.17M	4,568.18%1.97M	----	----	77.33%-929K	87.63%-83K	97.99%-44K	-53.99%-328K
Change In working capital	90.10%-1.38M	18.19%8.02M	84.98%6.21M	80.67%-1.23M	13,186.92%17.01M	-240.64%-13.97M	149.60%6.79M	217.55%3.36M	37.28%-6.37M	-101.18%-130K
-Change in receivables	87.17%-289K	-20.15%9.42M	726.18%5.19M	336.88%1.76M	-47.19%4.72M	-150.81%-2.25M	148.54%11.8M	90.40%-829K	96.09%-743K	6.09%8.94M
-Change in prepaid assets	100.40%18K	-75.50%182K	299.90%3.81M	-201.93%-2.59M	234.60%3.46M	-267.82%-4.5M	239.40%743K	7.12%-1.91M	-63.54%2.54M	-171.31%-2.57M
-Change in payables and accrued expense	78.56%-1.56M	39.31%-3.71M	-153.38%-3.04M	92.31%-579K	205.45%7.2M	-386.47%-7.29M	-150.40%-6.11M	-31.01%5.7M	-450.42%-7.53M	-287.42%-6.82M
-Change in other current assets	73.86%1.45M	7.65%4.49M	68.98%1.44M	116.39%1.16M	-21.59%1.06M	-41.92%834K	-23.00%4.17M	-39.17%851K	-63.07%537K	-4.60%1.35M
-Change in other current liabilities	-36.99%-1.04M	38.11%-2.36M	-159.39%-1.19M	15.78%-987K	156.44%574K	34.91%-757K	40.46%-3.81M	74.89%-458K	30.81%-1.17M	31.65%-1.02M
-Change in other working capital	860.00%38K	----	----	----	----	---5K	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	29.89%-24.99M	-21.67%-103.15M	-39.06%-21.6M	-8.53%-32.13M	47.74%-13.78M	-168.56%-35.64M	-21.12%-84.78M	26.10%-15.53M	-0.33%-29.6M	-476.00%-26.38M
Investing cash flow
Cash flow from continuing investing activities	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M	48.41%54.9M	-61.16%28.23M	137.11%16.22M	-237.70%-35.06M
Net PPE purchase and sale	75.06%-787K	-326.26%-9.06M	4.80%-1.37M	-756.97%-2.15M	-3,120.27%-2.38M	-769.42%-3.16M	-183.33%-2.13M	-4,254.55%-1.44M	37.09%-251K	43.08%-74K
Net investment purchase and sale	-133.57%-12.33M	-178.08%-44.52M	-55.49%13.2M	-971.82%-143.6M	240.50%49.15M	-19.93%36.73M	51.09%57.02M	-59.20%29.67M	138.03%16.47M	-236.71%-34.98M
Cash from discontinued investing activities
Investing cash flow	-139.07%-13.12M	-197.60%-53.58M	-58.07%11.84M	-998.57%-145.75M	233.40%46.77M	-26.22%33.57M	48.41%54.9M	-61.16%28.23M	137.11%16.22M	-237.70%-35.06M
Financing cash flow
Cash flow from continuing financing activities	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K	550.42%20.03M	210.71%2.93M	500.58%4.12M	190.89%3.35M
Net issuance payments of debt	---7.17M	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	--0	-89.62%2.21M	--0	-95.15%200K	-76.80%882K	-89.18%1.13M	488.32%21.26M	210.82%2.93M	500.58%4.12M	230.03%3.8M
Net other financing activities	77.82%-183K	16,041.25%195.92M	-2,200.00%-23K	--199.68M	-545.01%-2.91M	-6.18%-825K	-130.15%-1.23M	---1K	--0	---451K
Cash from discontinued financing activities
Financing cash flow	-2,541.86%-7.35M	889.00%198.13M	-100.78%-23K	4,751.33%199.88M	-160.49%-2.03M	-96.88%301K	550.42%20.03M	210.71%2.93M	500.58%4.12M	190.89%3.35M
Net cash flow
Beginning cash position	86.31%89.36M	-17.04%47.96M	206.62%99.15M	85.46%77.15M	-53.66%46.19M	-17.04%47.96M	-34.11%57.81M	520.75%32.34M	-46.49%41.6M	78.94%99.68M
Current changes in cash	-2,466.63%-45.46M	520.16%41.39M	-162.64%-9.79M	337.52%22M	153.30%30.96M	-104.23%-1.77M	67.08%-9.85M	-70.29%15.63M	87.23%-9.26M	-363.62%-58.08M
End cash Position	-4.96%43.9M	86.31%89.36M	86.31%89.36M	206.62%99.15M	85.46%77.15M	-53.66%46.19M	-17.04%47.96M	-17.04%47.96M	520.75%32.34M	-46.49%41.6M
Free cash flow	33.56%-25.78M	-29.12%-112.21M	-35.35%-22.97M	-14.83%-34.28M	38.88%-16.17M	-184.56%-38.8M	-22.84%-86.91M	19.39%-16.97M	0.17%-29.85M	-461.67%-26.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall